PPCB

Propanc Biopharma, Inc. Common Stock

PPCB • NASDAQ

Propanc Biopharma, Inc. Common Stock is a publicly traded company trading on NASDAQ, led by CEO James Nathanielsz, with a market cap of $3.0M.

CEOJames Nathanielsz
Market Cap$3.0M

Next Earnings

Upcoming earnings announcement for Propanc Biopharma, Inc. Common Stock

Date
Thursday, February 19, 2026 (in 1 week)
Timing
Before Market Open (8:45 AM New York)
Fiscal Period
Q2 2026

Earnings History

Past 1 earnings report for Propanc Biopharma, Inc. Common Stock

DatePeriodEPSEPS SurpriseRevenueRev. SurpriseFiling
Nov 17, 2025Q1 2026
-$0.39
—
-
——

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.